Nu Skin Enterprises (NYSE: NUS – Get Assessed) had its price target lowered by Citigroup research analysts from $47.00 to $39.00 in a research note released Wednesday to investors, reports The Fly. Citigroup’s price target points to a potential upside of 8.76% from the stock’s previous close.
A number of other equity research analysts have also recently commented on NUS. DA Davidson reduced its target price on Nu Skin Enterprises from $45.00 to $40.00 and set a “neutral” rating for the company in a Tuesday, August 23 report. TheStreet upgraded Nu Skin Enterprises from a “b” to a “c” rating in a Thursday, August 4 research report. Finally, StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a Wednesday, June 22 research report.
Nu Skin Enterprises Stock Performance
Shares of Nu Skin Enterprises opened at $35.86 on Wednesday. The company has a market capitalization of $1.80 billion, a P/E ratio of 16.15 and a beta of 1.20. Nu Skin Enterprises has a 52-week minimum of $33.29 and a 52-week maximum of $56.76. The company has a quick ratio of 1.38, a current ratio of 2.30 and a leverage ratio of 0.41. The company’s 50-day moving average is $40.98 and its two-hundred-day moving average is $43.89.
Nu Skin Enterprises (NYSE:NUS – Get Rating) last released its quarterly earnings data on Thursday, August 4. The company reported earnings per share of $0.77 for the quarter, missing the consensus estimate of $0.79 per ($0.02). The company posted revenue of $560.62 million in the quarter, versus analyst estimates of $559.91 million. Nu Skin Enterprises achieved a net margin of 4.57% and a return on equity of 19.78%. Research analysts expect Nu Skin Enterprises to post an EPS of 3.38 for the current fiscal year.
Insider Buying and Selling at Nu Skin Enterprises
In other Nu Skin Enterprises news, CEO Ryan S. Napierski sold 25,000 shares of Nu Skin Enterprises in a trade dated Thursday, August 25. The stock was sold at an average price of $42.99, for a total value of $1,074,750.00. Following the completion of the sale, the CEO now owns 122,683 shares of the company, valued at approximately $5,274,142.17. The transaction was disclosed in a document filed with the Securities & Exchange Commission, accessible via this link. In other news, CEO Ryan S. Napierski sold 25,000 shares of Nu Skin Enterprises in a trade dated Thursday, August 25. The stock was sold at an average price of $42.99, for a total value of $1,074,750.00. As a result of the transaction, the CEO now directly owns 122,683 shares of the company, valued at approximately $5,274,142.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, accessible via the SEC’s website. Additionally, director Andrew D. Lipman sold 1,000 shares of Nu Skin Enterprises in a trade dated Thursday, September 22. The shares were sold at an average price of $36.67, for a total value of $36,670.00. Following completion of the transaction, the administrator now directly owns 69,393 shares of the company, valued at $2,544,641.31. The disclosure of this sale can be found here. Insiders sold 29,602 shares of the company worth $1,262,212 in the past 90 days. 2.80% of the shares are held by insiders of the company.
Hedge funds weigh on Nu Skin Enterprises
Hedge funds and other institutional investors have recently changed their holdings in the company. Artemis Wealth Advisors LLC acquired a new position in Nu Skin Enterprises during Q2 worth approximately $33,000. Eagle Bay Advisors LLC increased its position in Nu Skin Enterprises by 37.1% during the 2nd quarter. Eagle Bay Advisors LLC now owns 809 shares of the company worth $35,000 after acquiring 219 additional shares in the last quarter. Private Trust Co. NA acquired a new position in Nu Skin Enterprises during Q2 worth approximately $103,000. Gladius Capital Management LP increased its position in Nu Skin Enterprises by 18.2% during the 1st quarter. Gladius Capital Management LP now owns 2,278 shares of the company worth $110,000 after acquiring 351 additional shares in the last quarter. Finally, Point72 Hong Kong Ltd acquired a new position in Nu Skin Enterprises during Q2 worth approximately $144,000. 88.20% of the shares are held by institutional investors and hedge funds.
About Nu Skin Enterprises
(Get a rating)
Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems and ageLOC LumiSpa skin cleansing and treatment devices; and ageLOC Boost, plus a range of other cosmetic and personal care products.
This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Before you consider Nu Skin Enterprises, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes hold…and Nu Skin Enterprises wasn’t on the list.
While Nu Skin Enterprises currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the five actions here